Hahnen, E. T., & Schneeweiss, A. (2017). Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer: Secondary analysis of the geparsixto randomized clinical trial. JAMA oncology, 3(10), . https://doi.org/10.1001/jamaoncol.2017.1007
Chicago-Zitierstil (17. Ausg.)Hahnen, Eric Thomas, und Andreas Schneeweiss. "Germline Mutation Status, Pathological Complete Response, and Disease-free Survival in Triple-negative Breast Cancer: Secondary Analysis of the Geparsixto Randomized Clinical Trial." JAMA Oncology 3, no. 10 (2017). https://doi.org/10.1001/jamaoncol.2017.1007.
MLA-Zitierstil (9. Ausg.)Hahnen, Eric Thomas, und Andreas Schneeweiss. "Germline Mutation Status, Pathological Complete Response, and Disease-free Survival in Triple-negative Breast Cancer: Secondary Analysis of the Geparsixto Randomized Clinical Trial." JAMA Oncology, vol. 3, no. 10, 2017, https://doi.org/10.1001/jamaoncol.2017.1007.